Vemurafenib Recruiting Phase 0 Trials for Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT01748149Vemurafenib in Children With Recurrent/Refractory BRAFV600E-mutant Gliomas